ENALAPRIL, ATENOLOL, AND HYDROCHLOROTHIAZIDE IN MILD TO MODERATE HYPERTENSION - A COMPARATIVE MULTICENTER STUDY IN GENERAL-PRACTICE IN NORWAY

被引:117
作者
HELGELAND, A [1 ]
HAGELUND, CH [1 ]
STROMMEN, R [1 ]
TRETLI, S [1 ]
机构
[1] UNIV OSLO,DEPT PHARMACOTHERAPEUT,OSLO 3,NORWAY
关键词
D O I
10.1016/S0140-6736(86)90985-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:872 / 875
页数:4
相关论文
共 23 条
[1]  
AMES RP, 1976, LANCET, V1, P721
[2]  
[Anonymous], 1984, Br J Clin Pharmacol, V18, P51
[3]  
[Anonymous], 1981, LANCET, V2, P539
[4]  
[Anonymous], 1982, JAMA, V248, P1465
[5]  
ARR SM, 1984, BR J CLIN PHARM, V18, P292
[6]   SIDE-EFFECTS OF HYPOTENSIVE AGENTS EVALUATED BY A SELF-ADMINISTERED QUESTIONNAIRE [J].
BULPITT, CJ ;
DOLLERY, CT .
BRITISH MEDICAL JOURNAL, 1973, 3 (5878) :485-490
[7]   ENALAPRIL WORLDWIDE EXPERIENCE [J].
DAVIES, RO ;
IRVIN, JD ;
KRAMSCH, DK ;
WALKER, JF ;
MONCLOA, F .
AMERICAN JOURNAL OF MEDICINE, 1984, 77 (2A) :23-35
[8]   METABOLIC CONSEQUENCES OF ATENOLOL AND PROPRANOLOL IN TREATMENT OF ESSENTIAL HYPERTENSION [J].
DAY, JL ;
SIMPSON, N ;
METCALFE, J ;
PAGE, RL .
BRITISH MEDICAL JOURNAL, 1979, 1 (6156) :77-80
[9]  
Effects of treatment on morbidity in hypertension, 1970, JAMA-J AM MED ASSOC, V213, P1143
[10]  
GROOP L, 1983, ACTA MED SCAND, V213, P9